Comparison of the Effects of Pioglitazone versus Placebo when Given in Addition to Standard Insulin Treatment in Patients with Type 2 Diabetes Mellitus Requiring Hemodialysis: Results from the PIOren Study

BACKGROUND: Patients with type 2 diabetes mellitus and advanced kidney disease are usually treated with insulin. However, the prolonged pharmacokinetic insulin profile in patients with delayed renal insulin elimination impairs a successful therapy. Due to its hepatic metabolism, pioglitazone is a po...

Descripción completa

Detalles Bibliográficos
Autores principales: Galle, Jan, Kleophas, Werner, Dellanna, Frank, Schmid, Volkmar H.R., Forkel, Claudia, Dikta, Gerhard, Krajewski, Vera, Fuchs, Winfried, Forst, Thomas, Pfützner, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2012
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383235/
https://www.ncbi.nlm.nih.gov/pubmed/22739963
http://dx.doi.org/10.1159/000337334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3383235/
https://www.ncbi.nlm.nih.gov/pubmed/22739963
http://dx.doi.org/10.1159/000337334

Ejemplares similares